Forskolin increases the effect of everolimus on aromatase inhibitor-resistant breast cancer cells

Aromatase inhibitor (AI) resistance is a major obstacle in the treatment of estrogen receptor-positive breast cancer. Everolimus (EVE) ameliorates AI-resistant breast cancer and is therefore used in cancer treatment. However, some patients show resistance to EVE. Here, we used 30 clones of long-term...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Oncotarget
Autori principali: Hayashi, Takanori, Hikichi, Masahiro, Yukitake, Jun, Wakatsuki, Toru, Nishio, Eiji, Utsumi, Toshiaki, Harada, Nobuhiro
Natura: Artigo
Lingua:Inglês
Pubblicazione: Impact Journals LLC 2018
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5955115/
https://ncbi.nlm.nih.gov/pubmed/29805747
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.25217
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi